⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 2, 2024

Table S9 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates

Joshua D. Thomas Aleksandr V. Yurkovetskiy Mao Yin Natalya D. Bodyak Shuyi Tang Marina Protopopova Eugene Kelleher Brian Jones Liping Yang Daniel Custar Kalli C. Catcott Damon R. Demady Scott D. Collins Ling Xu Charlie Bu LiuLiang Qin Elena Ter‐Ovanesyan Marc Damelin Dorin Toader Timothy B. Lowinger

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Table shows Cytotoxicity Data for Platforms 18 vs 19

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Thomas et al. (2024) studied this question.

synapsesocial.com/papers/68e70c4bb6db643587685e4b https://doi.org/10.1158/1535-7163.25523463

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S9 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates2024
2Table S6 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates2024
3Table S6 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates2024
4Table S3 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates2024
5Table S3 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates2024

More related papers

Table S7 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates2024
Table S7 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates2024
Table S8 from Development of a Novel DNA Mono-alkylator Platform for Antibody–Drug Conjugates2024